New drug duo aims to stall advanced prostate cancer

NCT ID NCT03732820

Ongoing Disease control Sponsor: AstraZeneca Source: ClinicalTrials.gov ↗

Summary

This large, late-stage study tested whether adding a drug called olaparib to the standard treatment (abiraterone) is better at controlling advanced prostate cancer that has stopped responding to hormone therapy. It involved nearly 900 men worldwide who had not yet tried other treatments for this advanced stage. The goal was to see if the combination could delay cancer growth and help patients live longer.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for METASTATIC CASTRATION-RESISTANT PROSTATE CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Research Site

Birmingham, Alabama, 35209, United States
Research Site

Anchorage, Alaska, 99503, United States
Research Site

Tucson, Arizona, 85704, United States
Research Site

Tucson, Arizona, 85741, United States
Research Site

Clovis, California, 93611, United States
Research Site

Los Angeles, California, 90027, United States
Research Site

Los Angeles, California, 90073, United States
Research Site

Sacramento, California, 95817, United States
Research Site

San Diego, California, 92123, United States
Research Site

Denver, Colorado, 80211, United States
Research Site

Lisle, Illinois, 60532, United States
Research Site

Jeffersonville, Indiana, 47130, United States
Research Site

New Orleans, Louisiana, 70112, United States
Research Site

Detroit, Michigan, 48202, United States
Research Site

Grand Rapids, Michigan, 49503, United States
Research Site

St Louis, Missouri, 63106, United States
Research Site

Bozeman, Montana, 59715, United States
Research Site

Omaha, Nebraska, 68130, United States
Research Site

Paramus, New Jersey, 07652, United States
Research Site

Brooklyn, New York, 11220, United States
Research Site

New Hyde Park, New York, 11042, United States
Research Site

Rochester, New York, 14642, United States
Research Site

Syracuse, New York, 13210, United States
Research Site

Durham, North Carolina, 27710, United States
Research Site

Philadelphia, Pennsylvania, 19111, United States
Research Site

Charleston, South Carolina, 29425, United States
Research Site

Myrtle Beach, South Carolina, 29572, United States
Research Site

Milwaukee, Wisconsin, 53226, United States
Research Site

Box Hill, 3128, Australia
Research Site

Darlinghurst, 2010, Australia
Research Site

Greenslopes, 4120, Australia
Research Site

Herston, 4029, Australia
Research Site

Kingswood, 2747, Australia
Research Site

Kurralta Park, 5037, Australia
Research Site

St Albans, 3021, Australia
Research Site

Waratah, 2298, Australia
Research Site

Ghent, 9000, Belgium
Research Site

Belo Horizonte, 30110-022, Brazil
Research Site

Curitiba, 80810-050, Brazil
Research Site

Fortaleza, 60336-232, Brazil
Research Site

Porto Alegre, 91350-200, Brazil
Research Site

Rio de Janeiro, 22793-080, Brazil
Research Site

São José do Rio Preto, 15090-000, Brazil
Research Site

São Paulo, 01221-020, Brazil
Research Site

São Paulo, 04266-010, Brazil
Research Site

Calgary, Alberta, T2V 1P9, Canada
Research Site

Edmonton, Alberta, T6G 1Z2, Canada
Research Site

Kelowna, British Columbia, V1Y 5L3, Canada
Research Site

Halifax, Nova Scotia, B3H 1V7, Canada
Research Site

London, Ontario, N6A 5W9, Canada
Research Site

Toronto, Ontario, M4N 3M5, Canada
Research Site

Toronto, Ontario, M5G 2M9, Canada
Research Site

Greenfield Park, Quebec, J4V 2H1, Canada
Research Site

Montreal, Quebec, H2X 3E4, Canada
Research Site

Montreal, Quebec, H3T 1E2, Canada
Research Site

Santiago, 7500787, Chile
Research Site

Santiago, 7520349, Chile
Research Site

Temuco, 4781156, Chile
Research Site

Viña del Mar, 2540488, Chile
Research Site

Brno, 656 53, Czechia
Research Site

Prague, 120 00, Czechia
Research Site

Prague, 140 59, Czechia
Research Site

Prague, 150 06, Czechia
Research Site

Angers, 49033, France
Research Site

Besançon, 25030, France
Research Site

Caen, 14076, France
Research Site

Pierre-Bénite, 69495, France
Research Site

Quimper, 29107, France
Research Site

Vandœuvre-lès-Nancy, 54519, France
Research Site

Bergisch Gladbach, 51465, Germany
Research Site

Bremen, 28277, Germany
Research Site

Cologne, 50968, Germany
Research Site

Duisburg, 47169, Germany
Research Site

Freiburg im Breisgau, 79106, Germany
Research Site

Heinsberg, 52525, Germany
Research Site

Mettmann, 40822, Germany
Research Site

Nuremberg, 90419, Germany
Research Site

Nürtingen, 72622, Germany
Research Site

Ulm, 89081, Germany
Research Site

Milan, 20133, Italy
Research Site

Milan, 20141, Italy
Research Site

Naples, 80131, Italy
Research Site

Orbassano, 10043, Italy
Research Site

Pavia, 27100, Italy
Research Site

Bunkyō City, 113-8431, Japan
Research Site

Hirakata-shi, 573-1191, Japan
Research Site

Kanazawa, 920-8641, Japan
Research Site

Kashihara-shi, 634-8522, Japan
Research Site

Kawagoe-shi, 350-8550, Japan
Research Site

Kita-gun, 761-0793, Japan
Research Site

Kyoto, 606-8507, Japan
Research Site

Maebashi, 371-8811, Japan
Research Site

Miyazaki, 889-1692, Japan
Research Site

Nagoya, 466-8560, Japan
Research Site

Osaka, 541-8567, Japan
Research Site

Osaka, 545-8586, Japan
Research Site

Osakasayama-shi, 589-8511, Japan
Research Site

Sagamihara-shi, 252-0375, Japan
Research Site

Sakura-shi, 285-8741, Japan
Research Site

Shinjuku-ku, 160-8582, Japan
Research Site

Toon-shi, 791-0295, Japan
Research Site

Yokohama, 232-0024, Japan
Research Site

Hilversum, 1213 XZ, Netherlands
Research Site

Nijmegen, 6525 GA, Netherlands
Research Site

Tilburg, 5042 AD, Netherlands
Research Site

Bratislava, 851 05, Slovakia
Research Site

Prešov, 08001, Slovakia
Research Site

Šaľa, 92701, Slovakia
Research Site

Trenčín, 911 01, Slovakia
Research Site

Daegu, 41404, South Korea
Research Site

Goyang-si, 10408, South Korea
Research Site

Seoul, 03080, South Korea
Research Site

Seoul, 03722, South Korea
Research Site

Seoul, 05505, South Korea
Research Site

Seoul, 06591, South Korea
Research Site

Barcelona, 08036, Spain
Research Site

Girona, 17007, Spain
Research Site

Madrid, 08035, Spain
Research Site

Madrid, 28041, Spain
Research Site

Málaga, 29010, Spain
Research Site

Seville, 41009, Spain
Research Site

Adana, 01060, Turkey (Türkiye)
Research Site

Ankara, 06590, Turkey (Türkiye)
Research Site

Ankara, 06800, Turkey (Türkiye)
Research Site

Cordaleo, 35575, Turkey (Türkiye)
Research Site

Istanbul, 34030, Turkey (Türkiye)
Research Site

Izmir, 35360, Turkey (Türkiye)
Research Site

Guildford, GU2 7WG, United Kingdom
Research Site

Manchester, M20 4BX, United Kingdom
Research Site

Sheffield, S10 2SJ, United Kingdom
Research Site

Southampton, SO16 6YD, United Kingdom
Research Site

Swansea, SA2 8QA, United Kingdom

Conditions

Explore the condition pages connected to this study.

METASTATIC CASTRATION-RESISTANT PROSTATE CANCER